trending Market Intelligence /marketintelligence/en/news-insights/trending/j2jd-khatdcwqvbsckux4a2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Cancer therapy developer Athenex appoints director

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


Cancer therapy developer Athenex appoints director

Buffalo, N.Y.-based biopharmaceutical company Athenex Inc. appointed Benson Tsang as a board member.

The cancer therapy developer said the appointment is effective July 1, the same day James Zukin steps down from the board.

Tsang, who has over three decades of financial and general management experience, is the former CFO of WuXi Pharmatech Inc.

Tsang currently provides financial and operational advisory services through his consultancy firm to clients in the USA, Canada and China, Athenex said in a statement.